Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Metastatic Breast Cancer, BRCA, PARP

Debu Tripathy

MD

🏢MD Anderson Cancer Center🌐USA

Professor and Chair

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Debu Tripathy at MD Anderson has contributed to metastatic breast cancer clinical research across subtypes. His work spans BRCA-mutant breast cancer PARP inhibitor trials, CDK4/6 inhibitor combinations, and novel therapy development for metastatic breast cancer. His leadership in breast oncology clinical trials and his contributions to treatment guidelines have been important.

Share:

🧪Research Fields 研究领域

metastatic breast cancer treatment
BRCA germline breast PARP inhibitors
talazoparib olaparib breast
breast cancer clinical trials
HR+ metastatic breast cancer CDK4-6

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Debu Tripathy 的研究动态

Follow Debu Tripathy's research updates

留下邮箱,当我们发布与 Debu Tripathy(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment